|
⚲
|
| Keyboard |
| Mark Fishman | |
|---|---|
| Firm | Aditum Bio Management Company LLC |
| Address | 1111 Broadway, Suite 1300 Oakland, CA 94607 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Aditum Bio Management Company LLC | |||||
| Aditum Bio Fund 3 LP | 021-514797 | Director | of 400.0 M |
413.7 M | |
| Aditum Bio Fund 2 LP | 021-406276 | Director | of 250.0 M |
179.6 M | |
| Aditum Bio Fund 1 LP | 021-344544 | Director | 133.0 M of 133.0 M |
179.5 M | |
| Beam Therapeutics Inc | 021-335722 | Director | 135.0 M of 135.0 M |
||
| Beam Therapeutics Inc | 021-318897 | Director | 83.6 M of 83.6 M |
||
| Semma Therapeutics Inc | 021-300037 | Director | 113.9 M of 119.9 M |
||
| 1601 West Division LLC | 021-188543 | Executive Officer | 5.2 M of 5.2 M |
||
| BNA Chicago LLC | 021-168607 | Executive Officer | 1.9 M of 8.0 M |
||
| Aesir Capital Management LP | |||||
| Aesir Credit Offshore Ltd | 021-186753 | Executive Officer | 0.2 M | 5.8 M | |
| Aesir Credit Partners LP | 021-179261 | Executive Officer | 68.2 M | 56.2 M | |